Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Oct 26, 2018 (8 years ago)

deb stoko (Benzalkonium Chloride)

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: Product was released to market prior to microbiological testing.

Cause type: Microbial contamination

Bacteria, mold, yeast or other microorganisms detected in the product. Contamination can occur from water systems, equipment or handling, and can cause infection. All microbial contamination recalls.

What was recalled

deb stoko, Refresh AntiBac FOAM (benzalkonium chloride), 0.13%, 1 L (33.8 fl. oz.) cartridge packaged in 8 cartridges per case, Made in the USA, Deb USA, Inc., Charlotte, NC 28217, NDC 11084-010-27.

Affected NDC 11084-0010-27

Compare with the code on your package — it is the most precise check available.

Drug: Benzalkonium

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Refresh AntiBac FOAM
Benzalkonium Chloride
NDC 11084-0010
.13 g/L Soap
Topical
SC Johnson Professional USA Inc. OTC
Recalling firm
S.C. Johnson Professional
NDC code
11084-010-27
Origin
NC, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0220-2019 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Benzalkonium recalls

See all
Class II · Moderate risk

Revitaderm Wound Care

CGMP Deviations; product manufactured in the same facility under the same conditions as the product found to be contaminated

Ongoing cGMP deviation Blaine Labs Inc NDC 63347-120-02 D-0699-2026
Class I · High risk

Revitaderm Wound Care Gel

Microbial contamination of Non-Sterile Product: samples identified the presence of Lysinibacillus fusiformis and other Bacillus spp

Ongoing Microbial contamination Blaine Labs Inc NDC 63347-120-02 D-0692-2026

Other recalls by S.C. Johnson Professional

All 2018 recalls